NOX1 Polyclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIPA5103220-Each-of-1 | In Stock | ₹ 46,858.50 |
PIPA5103220 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 46,858.50
GST (18%): ₹ 8,434.53
Total Price: ₹ 55,293.03
Antigen
NOX1
Classification
Polyclonal
Conjugate
Unconjugated
Gene
Nox1
Gene Alias
GP91 phox homolog; GP91-2; mitogenic oxidase (pyridine nucleotide-dependent superoxide-generating); mitogenic oxidase 1; MOX1; MOX-1; NADH/NADPH mitogenic oxidase subunit P65-MOX; NADPH oxidase 1; NADPH oxidase 1 alpha; NADPH oxidase homolog-1; NOH1; NOH-1; Nox1; NOX-1; NOX1a; NOX1alpha
Host Species
Rabbit
Purification Method
Affinity chromatography
Regulatory Status
RUO
Gene ID (Entrez)
114243, 237038, 27035
Content And Storage
-20°C
Form
Liquid
Applications
Immunocytochemistry, Immunohistochemistry (Paraffin), Western Blot
Concentration
1 mg/mL
Formulation
PBS with 50% glycerol and 0.02% sodium azide; pH 7.4
Gene Accession No.
Q8CIZ9, Q9WV87, Q9Y5S8
Gene Symbols
Nox1
Immunogen
A synthesized peptide derived from human NOX1(Accession Q9Y5S8), corresponding to amino acid residues R471-H521.
Quantity
100 μL
Primary or Secondary
Primary
Target Species
Human, Mouse, Rat
Product Type
Antibody
Isotype
IgG
Related Products
Description
- Antibody detects endogenous levels of total NOX1
- Voltage-gated proton (hydrogen) channels play an important role in cellular defense against acidic stress
- NOX1 is a homolog of the catalytic subunit of the superoxide-generating NADPH oxidase of phagocytes, gp91phox
- Three splice variants of NOX1 have been identified, NOH-1L, NOH-1S and NOH-1Lv
- NOH-1S is a voltage-gated proton channel that participates in the regulation of cellular pH and is blocked by zinc
- NOH-1L is a pyridine nucleotide-dependent oxidoreductase that generates superoxide and might conduct H (+) ions as part of its electron transport mechanism, whereas NOH-1S does not contain an electron transport chain
- NOX1 have the potential to be effective treatments for a range of ischemic diseases.